Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?

TheMotleyFool

0 0

Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?

Intellia Therapeutics (NASDAQ: NTLA) and CRISPR Therapeutics (NASDAQ: CRSP) are pioneers in developing CRISPR gene-editing therapies. In this Motley Fool Live video recorded on Nov. 10, 2021, Motley Fool contributors Keith Speights and Brian Orelli address a viewer's question about a potentially major safety risk that both of these companies face.

Source Fool.com

Like: 0

NTLA

Share